• Home
  • Contact

Tag: Immuno-oncology

News

Duke Street Bio enters stage with next-generation cancer therapies

2 days ago 1 Likes 7
News

Immunocore Approval Opens Door for TCR Cancer Drugs

4 months ago 6 Likes 113
News

Norwegian Biotech Put on the Map with €20M Oncology Round

4 months ago 6 Likes 92
News

APT Blazes US Venture Capital Trail into European Biotech Startups

5 months ago 12 Likes 128
News

How is Spatial Transcriptomics Changing the Immuno-Oncology Field?

6 months ago 14 Likes 151
News

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

8 months ago 14 Likes 317
News

Microbiome Medicines Could Power Up CAR-T Cell Therapies

10 months ago 13 Likes 244
News

Europe’s TCR Therapy Scene Gains Traction with €40M Series B

10 months ago 7 Likes 165
News

June’s European Biotech Funding Zoomed In on Oncology and Neurology

11 months ago 13 Likes 194
News

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

11 months ago 9 Likes 194

Posts navigation

1 2 Next »
[cm_ad_changer group_id="3"]

Recent Posts

  • Blue Lake Biotechnology RSV vaccine gets FDA fast track
  • Companies partner on early lung cancer detection blood test
  • Animal-free milk company Imagindairy reaches $28M in funding
  • Labiotech goes global
  • Duke Street Bio enters stage with next-generation cancer therapies
  • Vaccines mobilized to control monkeypox outbreak
  • The organoid era: Bringing patient-relevant preclinical models to the lab
  • The coming of age of European synthetic biology
  • Zealand Pharma’s drug for rare metabolic disease smashes phase III
  • Evotec, Sernova in partnership to develop beta cell diabetes therapy
[cm_ad_changer group_id="4"]
[cm_ad_changer group_id="5"]
© 2020 biotechTODAY - Designed by Legendary Group